GlassScriptPhysician profile
Ann C Nunez
NPI 1356335871
$545.52
in general payments reported to CMS, 2019-2025
11 companies · $84.04 in 2025
The $84.04 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.10 · 2021: $66.55 · 2022: $53.99 · 2023: $79.30 · 2024: $175 · 2025: $84.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $149.53 | 2023-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $122.07 | 2021-2023 | Intellis Adaptivestim |
| Abbvie INC. | $65.32 | 2024 | |
| Vertos Medical, INC. | $38.48 | 2019-2021 | |
| Kaleo, INC. | $36.33 | 2019 | |
| Virtus Pharmaceuticals LLC | $31.78 | 2024 | Levorphanol Tartrate |
| Spr Therapeutics, INC | $30.28 | 2024 | Sprint Pns System |
| Abbott Laboratories | $23.26 | 2025 | Eterna |
| Boston Scientific Corporation | $20.71 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.99 | 2019 | |
| Biodelivery Sciences International, INC. | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Nunez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.